Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer (vol 349, pg 876, 2022)JOURNAL OF CONTROLLED RELEASEIF11.52022-10-010PRE
Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancerJOURNAL OF CONTROLLED RELEASEIF11.52022-09-018PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向